Medical research

FDA approves immunotherapy for dMMR endometrial cancer

The anti-programmed death receptor 1 (PD-1) monotherapy Jemperli (dostarlimab) received approval for treatment of mismatch repair-deficient (dMMR) recurrent or advanced endometrial cancer that has progressed after treatment ...

Oncology & Cancer

An IUD could ward off endometrial cancer in women at risk

For some patients who have early endometrial cancer or a precancerous condition, a hysterectomy may not be a good option because of serious health issues or the desire to preserve fertility.

Oncology & Cancer

IUD saving fertility for women with cancer

A common intrauterine device (IUD) could help preserve fertility and reduce the need for hysterectomies for women suffering endometrial cancer, according to University of Queensland research.

Obstetrics & gynaecology

Q and A: Spotting, perimenopause and menopause

Dear Mayo Clinic: I am 52 and recently had gone 10 months without a period, so I had assumed I was in menopause. But, over the past three months, I've noticed some light spotting. Does this mean I'm not in menopause? How ...

Oncology & Cancer

Every pregnancy helps reduce endometrial cancer risk

New QIMR Berghofer research has found each additional pregnancy a woman experiences, including those that result in miscarriage, can help reduce her risk of developing endometrial cancer.

Oncology & Cancer

Q&A: Understanding endometrial cancer

DEAR MAYO CLINIC: My 54-year-old sister was diagnosed recently with early stage endometrial cancer. She only went to the doctor because she had bleeding between menstrual cycles. I'm wondering if I am at risk, too, and if ...

page 8 from 18